跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
NMPA
/
Lenvatinib Mesilate Capsules
Approved
化学药品
Lenvatinib Mesilate Capsules
EISAI EUROPE LIMITED
🇨🇳 National Medical Products Administration
Approval Date
Jun 7, 2023
Approval ID
888G7YqTHfJ
Company
EISAI EUROPE LIMITED
Type
化学药品
Approval Details
Approval Id
888G7YqTHfJ
Approval Number
国药准字HJ20200044
Generic Name
甲磺酸仑伐替尼胶囊
Generic Name En
Lenvatinib Mesilate Capsules
Trade Name
乐卫玛
Brand Name
乐卫玛
Drug Type
化学药品
Dosage Form
胶囊剂
Strength
4mg(按C₂₁H₁₉ClN₄O₄计算)
Reg Date
2023-06-07
Expired Date
2028-06-06
Company Name
EISAI EUROPE LIMITED
Production Company Name
EISAI CO
Company Detail Path
/organization/eisai-europe-limited
Production Company Detail Path
/organization/eisai-co
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Jun 7, 2023
Approval ID
888G7YqTHfJ
Type
化学药品
Back to NMPA Approvals
乐卫玛 - NMPA Drug Approval Details